id,age,gender,cancer_type,diagnosis_status,tumor_characteristics,treatment_history,genetic_mutations,ecog_performance_status,organ_function_status,presence_of_metastases,clinical_pathological_risk_features,comorbidities,previous_cancer_history,pregnancy_breastfeeding_status,compliance_with_study_protocol
1,54,Female,Breast Cancer,newly diagnosed,"Size: 5cm, Grade: 3, ER/PR: Negative, HER2: Positive, Ki67: 92%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, Radiotherapy",,0,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
2,79,Female,Breast Cancer,relapsed,"Size: 5cm, Grade: 1, ER/PR: Negative, HER2: Positive, Ki67: 63%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Endocrine Therapy, Radiotherapy",,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
3,77,Female,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 2, ER/PR: Positive, HER2: Positive, Ki67: 26%","Neoadjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, ",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
4,28,Female,Breast Cancer,relapsed,"Size: 2cm, Grade: 2, ER/PR: Positive, HER2: Negative, Ki67: 39%","Targeted Therapy, Endocrine Therapy, Radiotherapy",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,f
5,63,Male,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 51%","Targeted Therapy, Endocrine Therapy, Radiotherapy",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
6,23,Female,Breast Cancer,newly diagnosed,"Size: 6cm, Grade: 1, ER/PR: Positive, HER2: Positive, Ki67: 42%","Neoadjuvant Chemotherapy, ",,3,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,f
7,24,Female,Breast Cancer,newly diagnosed,"Size: 6cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 41%","Neoadjuvant Chemotherapy, ",TP53,0,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
8,34,Female,Breast Cancer,relapsed,"Size: 5cm, Grade: 3, ER/PR: Positive, HER2: Positive, Ki67: 87%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, Radiotherapy",,0,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
9,68,Female,Breast Cancer,relapsed,"Size: 3cm, Grade: 2, ER/PR: Positive, HER2: Positive, Ki67: 85%","Adjuvant Chemotherapy, Endocrine Therapy, Radiotherapy",,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
10,43,Female,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 3, ER/PR: Negative, HER2: Positive, Ki67: 12%","Adjuvant Chemotherapy, Targeted Therapy, ",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
11,80,Female,Breast Cancer,newly diagnosed,"Size: 6cm, Grade: 3, ER/PR: Negative, HER2: Positive, Ki67: 62%","Neoadjuvant Chemotherapy, Endocrine Therapy, Radiotherapy",TP53,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
12,23,Male,Breast Cancer,newly diagnosed,"Size: 5cm, Grade: 4, ER/PR: Positive, HER2: Negative, Ki67: 50%","Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, ",,2,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
13,50,Female,Breast Cancer,newly diagnosed,"Size: 1cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 5%","Neoadjuvant Chemotherapy, ",,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
14,20,Female,Breast Cancer,relapsed,"Size: 2cm, Grade: 3, ER/PR: Negative, HER2: Positive, Ki67: 79%","Adjuvant Chemotherapy, Targeted Therapy, ","PIK3CA, ",2,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
15,55,Female,Breast Cancer,newly diagnosed,"Size: 1cm, Grade: 3, ER/PR: Positive, HER2: Positive, Ki67: 38%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, ",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
16,73,Female,Breast Cancer,newly diagnosed,"Size: 1cm, Grade: 2, ER/PR: Positive, HER2: Negative, Ki67: 44%","Neoadjuvant Chemotherapy, ","BRCA1, ",1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
17,77,Female,Breast Cancer,relapsed,"Size: 2cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 46%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, ",TP53,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
18,46,Female,Breast Cancer,newly diagnosed,"Size: 5cm, Grade: 2, ER/PR: Positive, HER2: Negative, Ki67: 60%","Neoadjuvant Chemotherapy, Targeted Therapy, ","PIK3CA, BRCA2, ",2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
19,49,Female,Breast Cancer,relapsed,"Size: 2cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 60%","Adjuvant Chemotherapy, ",,1,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
20,64,Female,Breast Cancer,newly diagnosed,"Size: 1cm, Grade: 2, ER/PR: Positive, HER2: Positive, Ki67: 43%","Adjuvant Chemotherapy, ","BRCA2, ",1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
21,35,Female,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 59%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Endocrine Therapy, Radiotherapy",,1,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
22,39,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 3, ER/PR: Negative, HER2: Negative, Ki67: 51%","Neoadjuvant Chemotherapy, Endocrine Therapy, Radiotherapy","BRCA2, ",2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
23,79,Female,Breast Cancer,relapsed,"Size: 2cm, Grade: 1, ER/PR: Positive, HER2: Negative, Ki67: 54%","Adjuvant Chemotherapy, Targeted Therapy, Radiotherapy",TP53,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
24,31,Female,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 4, ER/PR: Negative, HER2: Negative, Ki67: 52%","Neoadjuvant Chemotherapy, Targeted Therapy, Radiotherapy",,3,Normal,f,Risk features,Comorbidities,Previous cancer history,Pregnant/Breastfeeding,f
25,65,Female,Breast Cancer,newly diagnosed,"Size: 1cm, Grade: 3, ER/PR: Negative, HER2: Positive, Ki67: 84%","Adjuvant Chemotherapy, Targeted Therapy, Radiotherapy",,3,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
26,20,Female,Breast Cancer,relapsed,"Size: 4cm, Grade: 3, ER/PR: Positive, HER2: Positive, Ki67: 41%","Adjuvant Chemotherapy, Targeted Therapy, ",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
27,58,Female,Breast Cancer,relapsed,"Size: 2cm, Grade: 1, ER/PR: Negative, HER2: Positive, Ki67: 89%","Neoadjuvant Chemotherapy, Endocrine Therapy, ",TP53,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
28,36,Female,Breast Cancer,relapsed,"Size: 4cm, Grade: 4, ER/PR: Positive, HER2: Negative, Ki67: 20%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Radiotherapy",,0,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,f
29,75,Male,Breast Cancer,newly diagnosed,"Size: 5cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 20%","Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, ",,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
30,31,Female,Breast Cancer,relapsed,"Size: 3cm, Grade: 3, ER/PR: Negative, HER2: Negative, Ki67: 89%","Targeted Therapy, ","BRCA2, ",3,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
31,57,Female,Breast Cancer,relapsed,"Size: 1cm, Grade: 2, ER/PR: Positive, HER2: Positive, Ki67: 42%","Neoadjuvant Chemotherapy, Endocrine Therapy, ","PIK3CA, BRCA2, ",3,Impaired,f,Risk features,Comorbidities,Previous cancer history,Pregnant/Breastfeeding,t
32,67,Female,Breast Cancer,newly diagnosed,"Size: 5cm, Grade: 2, ER/PR: Negative, HER2: Positive, Ki67: 100%","Endocrine Therapy, ","BRCA2, TP53",2,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
33,68,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 4, ER/PR: Positive, HER2: Negative, Ki67: 93%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, Radiotherapy","PIK3CA, BRCA1, ",3,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
34,53,Male,Breast Cancer,relapsed,"Size: 4cm, Grade: 1, ER/PR: Positive, HER2: Negative, Ki67: 65%","Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, Radiotherapy",TP53,1,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
35,76,Female,Breast Cancer,newly diagnosed,"Size: 6cm, Grade: 4, ER/PR: Negative, HER2: Negative, Ki67: 11%","Adjuvant Chemotherapy, ",,2,Impaired,f,Risk features,Comorbidities,Previous cancer history,Pregnant/Breastfeeding,t
36,76,Female,Breast Cancer,newly diagnosed,"Size: 6cm, Grade: 3, ER/PR: Positive, HER2: Negative, Ki67: 98%","Adjuvant Chemotherapy, Endocrine Therapy, Radiotherapy",,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
37,46,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 2, ER/PR: Positive, HER2: Negative, Ki67: 34%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Endocrine Therapy, ","BRCA1, ",2,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,f
38,22,Male,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 4, ER/PR: Positive, HER2: Negative, Ki67: 64%","Adjuvant Chemotherapy, ",,3,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
39,41,Male,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 1, ER/PR: Negative, HER2: Negative, Ki67: 1%","Targeted Therapy, Endocrine Therapy, Radiotherapy",TP53,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
40,49,Female,Breast Cancer,newly diagnosed,"Size: 6cm, Grade: 2, ER/PR: Positive, HER2: Negative, Ki67: 11%","Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, ","BRCA2, ",2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
41,47,Female,Breast Cancer,newly diagnosed,"Size: 5cm, Grade: 3, ER/PR: Positive, HER2: Positive, Ki67: 10%","Neoadjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, Radiotherapy",,3,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
42,44,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 2, ER/PR: Positive, HER2: Negative, Ki67: 43%","Neoadjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, ",,3,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
43,48,Female,Breast Cancer,relapsed,"Size: 4cm, Grade: 3, ER/PR: Negative, HER2: Negative, Ki67: 58%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Endocrine Therapy, Radiotherapy","PIK3CA, ",3,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
44,62,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 2, ER/PR: Positive, HER2: Negative, Ki67: 7%","Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, ","BRCA1, ",2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,f
45,71,Female,Breast Cancer,newly diagnosed,"Size: 1cm, Grade: 1, ER/PR: Positive, HER2: Negative, Ki67: 82%","Adjuvant Chemotherapy, Endocrine Therapy, Radiotherapy","BRCA1, ",2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
46,77,Female,Breast Cancer,relapsed,"Size: 6cm, Grade: 3, ER/PR: Negative, HER2: Negative, Ki67: 56%","Targeted Therapy, Endocrine Therapy, Radiotherapy","BRCA1, ",3,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
47,66,Female,Breast Cancer,newly diagnosed,"Size: 5cm, Grade: 4, ER/PR: Negative, HER2: Positive, Ki67: 49%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, Radiotherapy",,3,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
48,72,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 4, ER/PR: Negative, HER2: Positive, Ki67: 65%","Adjuvant Chemotherapy, Endocrine Therapy, Radiotherapy",,0,Normal,f,Risk features,Comorbidities,Previous cancer history,Pregnant/Breastfeeding,t
49,68,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 4, ER/PR: Negative, HER2: Positive, Ki67: 26%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, ",,3,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
50,72,Female,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 1, ER/PR: Negative, HER2: Positive, Ki67: 73%","Neoadjuvant Chemotherapy, Targeted Therapy, Radiotherapy",,0,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,f
51,54,Male,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 2, ER/PR: Positive, HER2: Positive, Ki67: 81%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, ",,2,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,f
52,50,Female,Breast Cancer,newly diagnosed,"Size: 5cm, Grade: 2, ER/PR: Positive, HER2: Negative, Ki67: 17%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, ",,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,f
53,30,Female,Breast Cancer,newly diagnosed,"Size: 1cm, Grade: 2, ER/PR: Positive, HER2: Negative, Ki67: 13%","Neoadjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, Radiotherapy","BRCA2, TP53",3,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,f
54,48,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 1, ER/PR: Positive, HER2: Positive, Ki67: 99%","Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, ",,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
55,41,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 3, ER/PR: Positive, HER2: Negative, Ki67: 69%","Adjuvant Chemotherapy, Endocrine Therapy, Radiotherapy","BRCA2, ",3,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
56,47,Female,Breast Cancer,newly diagnosed,"Size: 6cm, Grade: 3, ER/PR: Positive, HER2: Positive, Ki67: 60%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, Radiotherapy",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
57,53,Female,Breast Cancer,newly diagnosed,"Size: 5cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 9%","Adjuvant Chemotherapy, Endocrine Therapy, Radiotherapy","BRCA2, ",1,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
58,67,Male,Breast Cancer,relapsed,"Size: 4cm, Grade: 2, ER/PR: Positive, HER2: Negative, Ki67: 41%","Neoadjuvant Chemotherapy, Radiotherapy",,1,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
59,49,Male,Breast Cancer,relapsed,"Size: 5cm, Grade: 1, ER/PR: Negative, HER2: Negative, Ki67: 84%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Endocrine Therapy, Radiotherapy","BRCA2, ",1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
60,59,Female,Breast Cancer,newly diagnosed,"Size: 1cm, Grade: 3, ER/PR: Positive, HER2: Negative, Ki67: 52%","Adjuvant Chemotherapy, Targeted Therapy, Radiotherapy",,1,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,f
61,47,Female,Breast Cancer,relapsed,"Size: 6cm, Grade: 2, ER/PR: Negative, HER2: Positive, Ki67: 100%",,"PIK3CA, ",2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
62,45,Female,Breast Cancer,relapsed,"Size: 3cm, Grade: 3, ER/PR: Negative, HER2: Negative, Ki67: 12%","Targeted Therapy, Endocrine Therapy, ",,3,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
63,27,Female,Breast Cancer,relapsed,"Size: 6cm, Grade: 3, ER/PR: Negative, HER2: Negative, Ki67: 23%","Adjuvant Chemotherapy, ","BRCA1, BRCA2, ",2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
64,26,Female,Breast Cancer,relapsed,"Size: 3cm, Grade: 4, ER/PR: Positive, HER2: Negative, Ki67: 3%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, ",,0,Impaired,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
65,57,Female,Breast Cancer,newly diagnosed,"Size: 6cm, Grade: 2, ER/PR: Positive, HER2: Negative, Ki67: 36%","Targeted Therapy, ",,0,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
66,63,Female,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 1, ER/PR: Positive, HER2: Negative, Ki67: 47%","Adjuvant Chemotherapy, Endocrine Therapy, Radiotherapy",,2,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
67,37,Female,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 3, ER/PR: Positive, HER2: Negative, Ki67: 71%","Adjuvant Chemotherapy, Targeted Therapy, Radiotherapy",,0,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
68,25,Male,Breast Cancer,newly diagnosed,"Size: 1cm, Grade: 4, ER/PR: Negative, HER2: Negative, Ki67: 74%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Endocrine Therapy, ",,2,Normal,t,Risk features,Comorbidities,Previous cancer history,Pregnant/Breastfeeding,t
69,30,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 1, ER/PR: Negative, HER2: Negative, Ki67: 40%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, Radiotherapy","PIK3CA, BRCA1, ",1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
70,51,Female,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 1, ER/PR: Positive, HER2: Negative, Ki67: 64%","Neoadjuvant Chemotherapy, ",,1,Impaired,f,Risk features,Comorbidities,Previous cancer history,Pregnant/Breastfeeding,t
71,74,Female,Breast Cancer,relapsed,"Size: 3cm, Grade: 3, ER/PR: Negative, HER2: Negative, Ki67: 94%","Neoadjuvant Chemotherapy, ",,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
72,29,Female,Breast Cancer,newly diagnosed,"Size: 6cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 88%","Neoadjuvant Chemotherapy, Radiotherapy",,1,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
73,27,Male,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 1, ER/PR: Positive, HER2: Positive, Ki67: 56%","Neoadjuvant Chemotherapy, Endocrine Therapy, ",,3,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
74,30,Female,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 4, ER/PR: Positive, HER2: Positive, Ki67: 42%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, ",,2,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
75,39,Female,Breast Cancer,relapsed,"Size: 1cm, Grade: 4, ER/PR: Positive, HER2: Negative, Ki67: 0%","Targeted Therapy, Endocrine Therapy, ",,0,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
76,63,Female,Breast Cancer,newly diagnosed,"Size: 6cm, Grade: 4, ER/PR: Positive, HER2: Negative, Ki67: 93%","Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, Radiotherapy","BRCA2, ",3,Impaired,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
77,72,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 14%","Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, Radiotherapy",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
78,29,Female,Breast Cancer,newly diagnosed,"Size: 1cm, Grade: 1, ER/PR: Negative, HER2: Negative, Ki67: 69%","Neoadjuvant Chemotherapy, ",,1,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
79,51,Male,Breast Cancer,newly diagnosed,"Size: 6cm, Grade: 2, ER/PR: Positive, HER2: Positive, Ki67: 87%","Targeted Therapy, Radiotherapy","BRCA2, TP53",2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
80,21,Female,Breast Cancer,newly diagnosed,"Size: 6cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 39%","Neoadjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, ","BRCA2, ",1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
81,30,Female,Breast Cancer,relapsed,"Size: 3cm, Grade: 4, ER/PR: Negative, HER2: Positive, Ki67: 92%","Adjuvant Chemotherapy, Endocrine Therapy, ",,0,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
82,77,Female,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 2, ER/PR: Positive, HER2: Negative, Ki67: 49%","Neoadjuvant Chemotherapy, Targeted Therapy, ",,3,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
83,62,Female,Breast Cancer,relapsed,"Size: 5cm, Grade: 1, ER/PR: Negative, HER2: Negative, Ki67: 98%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, Radiotherapy",,1,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
84,26,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 1, ER/PR: Positive, HER2: Negative, Ki67: 91%","Neoadjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, Radiotherapy","BRCA2, ",1,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
85,41,Female,Breast Cancer,relapsed,"Size: 6cm, Grade: 3, ER/PR: Negative, HER2: Negative, Ki67: 95%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, Radiotherapy",TP53,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
86,65,Female,Breast Cancer,relapsed,"Size: 6cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 51%","Endocrine Therapy, ",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
87,39,Male,Breast Cancer,relapsed,"Size: 2cm, Grade: 4, ER/PR: Negative, HER2: Negative, Ki67: 4%","Neoadjuvant Chemotherapy, Endocrine Therapy, ",,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
88,77,Female,Breast Cancer,newly diagnosed,"Size: 1cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 32%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Endocrine Therapy, ","BRCA1, ",1,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
89,35,Female,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 7%","Adjuvant Chemotherapy, Endocrine Therapy, ",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
90,60,Female,Breast Cancer,newly diagnosed,"Size: 6cm, Grade: 3, ER/PR: Positive, HER2: Positive, Ki67: 72%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, Radiotherapy",,3,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
91,55,Female,Breast Cancer,newly diagnosed,"Size: 1cm, Grade: 3, ER/PR: Negative, HER2: Negative, Ki67: 41%","Neoadjuvant Chemotherapy, Targeted Therapy, Radiotherapy",,1,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
92,74,Male,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 2, ER/PR: Negative, HER2: Positive, Ki67: 18%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, ","PIK3CA, ",1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
93,33,Female,Breast Cancer,relapsed,"Size: 5cm, Grade: 1, ER/PR: Negative, HER2: Negative, Ki67: 56%","Neoadjuvant Chemotherapy, Endocrine Therapy, ",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
94,71,Female,Breast Cancer,newly diagnosed,"Size: 1cm, Grade: 1, ER/PR: Positive, HER2: Negative, Ki67: 94%",Radiotherapy,"PIK3CA, ",2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
95,50,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 3%","Endocrine Therapy, ",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
96,20,Female,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 3, ER/PR: Negative, HER2: Positive, Ki67: 61%","Adjuvant Chemotherapy, Endocrine Therapy, ",,3,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,f
97,55,Male,Breast Cancer,relapsed,"Size: 1cm, Grade: 2, ER/PR: Positive, HER2: Positive, Ki67: 43%","Endocrine Therapy, ",,0,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
98,44,Female,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 3, ER/PR: Positive, HER2: Negative, Ki67: 94%","Targeted Therapy, Endocrine Therapy, ",,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
99,66,Female,Breast Cancer,newly diagnosed,"Size: 1cm, Grade: 3, ER/PR: Positive, HER2: Negative, Ki67: 39%","Adjuvant Chemotherapy, Endocrine Therapy, ",,3,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
100,76,Female,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 3, ER/PR: Positive, HER2: Negative, Ki67: 92%","Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, ",,3,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
101,28,Female,Breast Cancer,relapsed,"Size: 3cm, Grade: 3, ER/PR: Positive, HER2: Negative, Ki67: 91%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, Radiotherapy",TP53,3,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
102,18,Female,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 3, ER/PR: Positive, HER2: Negative, Ki67: 39%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Radiotherapy","BRCA2, TP53",0,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
103,20,Female,Breast Cancer,relapsed,"Size: 2cm, Grade: 3, ER/PR: Positive, HER2: Positive, Ki67: 19%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Endocrine Therapy, Radiotherapy",,0,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
104,48,Female,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 3, ER/PR: Negative, HER2: Positive, Ki67: 66%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Endocrine Therapy, ",TP53,0,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
105,32,Male,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 1, ER/PR: Positive, HER2: Positive, Ki67: 9%",Radiotherapy,,3,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
106,59,Female,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 48%","Neoadjuvant Chemotherapy, ",TP53,1,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
107,74,Male,Breast Cancer,newly diagnosed,"Size: 5cm, Grade: 3, ER/PR: Negative, HER2: Positive, Ki67: 2%","Targeted Therapy, Endocrine Therapy, ",,2,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
108,53,Female,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 1, ER/PR: Negative, HER2: Negative, Ki67: 82%","Neoadjuvant Chemotherapy, Targeted Therapy, Radiotherapy",,0,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
109,20,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 1, ER/PR: Negative, HER2: Positive, Ki67: 45%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Endocrine Therapy, ",,3,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,f
110,65,Female,Breast Cancer,relapsed,"Size: 5cm, Grade: 2, ER/PR: Positive, HER2: Negative, Ki67: 2%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, Radiotherapy",,1,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
111,31,Female,Breast Cancer,newly diagnosed,"Size: 5cm, Grade: 3, ER/PR: Negative, HER2: Negative, Ki67: 22%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, ",,2,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
112,36,Female,Breast Cancer,relapsed,"Size: 1cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 60%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, ","BRCA1, ",1,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
113,67,Female,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 2, ER/PR: Positive, HER2: Negative, Ki67: 100%","Adjuvant Chemotherapy, Targeted Therapy, Radiotherapy","PIK3CA, BRCA1, ",2,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
114,77,Female,Breast Cancer,newly diagnosed,"Size: 1cm, Grade: 3, ER/PR: Positive, HER2: Negative, Ki67: 80%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, ","BRCA2, ",2,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
115,77,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 2, ER/PR: Negative, HER2: Positive, Ki67: 69%",,,0,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
116,67,Female,Breast Cancer,newly diagnosed,"Size: 5cm, Grade: 1, ER/PR: Negative, HER2: Negative, Ki67: 91%","Neoadjuvant Chemotherapy, Targeted Therapy, Radiotherapy",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
117,29,Female,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 4, ER/PR: Positive, HER2: Positive, Ki67: 70%","Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, ",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
118,45,Female,Breast Cancer,relapsed,"Size: 4cm, Grade: 4, ER/PR: Negative, HER2: Positive, Ki67: 87%","Adjuvant Chemotherapy, Endocrine Therapy, ",,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Pregnant/Breastfeeding,t
119,43,Female,Breast Cancer,relapsed,"Size: 1cm, Grade: 3, ER/PR: Positive, HER2: Positive, Ki67: 36%",Radiotherapy,TP53,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
120,27,Female,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 54%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, ",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
121,59,Female,Breast Cancer,relapsed,"Size: 4cm, Grade: 1, ER/PR: Negative, HER2: Positive, Ki67: 28%","Targeted Therapy, Endocrine Therapy, ",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
122,55,Female,Breast Cancer,relapsed,"Size: 5cm, Grade: 3, ER/PR: Positive, HER2: Negative, Ki67: 73%","Neoadjuvant Chemotherapy, Endocrine Therapy, ",,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
123,30,Female,Breast Cancer,relapsed,"Size: 2cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 40%","Endocrine Therapy, Radiotherapy",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
124,38,Female,Breast Cancer,relapsed,"Size: 2cm, Grade: 3, ER/PR: Positive, HER2: Positive, Ki67: 69%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Endocrine Therapy, ",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
125,48,Female,Breast Cancer,relapsed,"Size: 3cm, Grade: 3, ER/PR: Positive, HER2: Negative, Ki67: 90%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, Radiotherapy",,1,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
126,36,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 3, ER/PR: Negative, HER2: Negative, Ki67: 24%","Adjuvant Chemotherapy, Radiotherapy","BRCA1, ",1,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
127,54,Female,Breast Cancer,relapsed,"Size: 6cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 63%","Adjuvant Chemotherapy, ","BRCA2, ",0,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
128,60,Male,Breast Cancer,newly diagnosed,"Size: 6cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 5%","Targeted Therapy, Radiotherapy",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Pregnant/Breastfeeding,t
129,45,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 4, ER/PR: Positive, HER2: Negative, Ki67: 32%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, Radiotherapy",TP53,3,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
130,22,Female,Breast Cancer,newly diagnosed,"Size: 6cm, Grade: 3, ER/PR: Positive, HER2: Negative, Ki67: 99%",,,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
131,67,Female,Breast Cancer,relapsed,"Size: 1cm, Grade: 4, ER/PR: Negative, HER2: Negative, Ki67: 89%","Targeted Therapy, ","PIK3CA, BRCA1, TP53",1,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
132,57,Female,Breast Cancer,newly diagnosed,"Size: 5cm, Grade: 4, ER/PR: Negative, HER2: Negative, Ki67: 37%","Targeted Therapy, Radiotherapy","BRCA2, ",3,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
133,18,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 41%","Neoadjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, Radiotherapy",,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
134,36,Female,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 4, ER/PR: Positive, HER2: Negative, Ki67: 62%","Targeted Therapy, ",,2,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
135,58,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 20%","Adjuvant Chemotherapy, Targeted Therapy, Radiotherapy",,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,f
136,52,Female,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 4, ER/PR: Positive, HER2: Negative, Ki67: 20%",,,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,f
137,76,Male,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 1, ER/PR: Negative, HER2: Positive, Ki67: 34%","Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, ",,3,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,f
138,52,Female,Breast Cancer,relapsed,"Size: 1cm, Grade: 2, ER/PR: Negative, HER2: Positive, Ki67: 44%","Neoadjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, ",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
139,43,Female,Breast Cancer,relapsed,"Size: 5cm, Grade: 3, ER/PR: Negative, HER2: Negative, Ki67: 46%","Adjuvant Chemotherapy, Endocrine Therapy, Radiotherapy",,0,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
140,43,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 4, ER/PR: Positive, HER2: Positive, Ki67: 74%","Neoadjuvant Chemotherapy, Radiotherapy",,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
141,32,Female,Breast Cancer,relapsed,"Size: 3cm, Grade: 3, ER/PR: Positive, HER2: Negative, Ki67: 74%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, Radiotherapy",,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
142,63,Female,Breast Cancer,relapsed,"Size: 4cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 60%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, ",,0,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
143,45,Female,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 1, ER/PR: Negative, HER2: Negative, Ki67: 81%","Adjuvant Chemotherapy, Targeted Therapy, Radiotherapy",,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
144,63,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 3, ER/PR: Positive, HER2: Positive, Ki67: 82%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, ","PIK3CA, ",0,Normal,f,Risk features,Comorbidities,Previous cancer history,Pregnant/Breastfeeding,t
145,57,Female,Breast Cancer,newly diagnosed,"Size: 6cm, Grade: 3, ER/PR: Negative, HER2: Positive, Ki67: 51%","Adjuvant Chemotherapy, Endocrine Therapy, Radiotherapy",,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
146,56,Female,Breast Cancer,newly diagnosed,"Size: 6cm, Grade: 1, ER/PR: Positive, HER2: Negative, Ki67: 61%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, Radiotherapy",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
147,43,Female,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 1, ER/PR: Negative, HER2: Negative, Ki67: 37%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Endocrine Therapy, Radiotherapy","BRCA1, ",1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
148,54,Female,Breast Cancer,relapsed,"Size: 5cm, Grade: 2, ER/PR: Positive, HER2: Positive, Ki67: 67%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, ","PIK3CA, TP53",2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
149,51,Female,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 2, ER/PR: Positive, HER2: Negative, Ki67: 89%",Radiotherapy,,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Pregnant/Breastfeeding,t
150,76,Female,Breast Cancer,newly diagnosed,"Size: 1cm, Grade: 2, ER/PR: Positive, HER2: Negative, Ki67: 98%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, ","BRCA1, ",1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
151,45,Male,Breast Cancer,relapsed,"Size: 6cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 17%","Neoadjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, Radiotherapy",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
152,35,Female,Breast Cancer,relapsed,"Size: 4cm, Grade: 4, ER/PR: Negative, HER2: Negative, Ki67: 29%","Targeted Therapy, Endocrine Therapy, Radiotherapy",,1,Impaired,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
153,40,Female,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 1, ER/PR: Positive, HER2: Positive, Ki67: 96%",Radiotherapy,,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
154,71,Male,Breast Cancer,newly diagnosed,"Size: 6cm, Grade: 3, ER/PR: Negative, HER2: Negative, Ki67: 88%",,,0,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
155,21,Female,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 1, ER/PR: Positive, HER2: Negative, Ki67: 73%","Neoadjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, ","BRCA1, ",2,Impaired,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
156,41,Female,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 54%","Adjuvant Chemotherapy, Targeted Therapy, ","BRCA2, ",1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,f
157,79,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 8%","Targeted Therapy, Endocrine Therapy, ",,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
158,76,Female,Breast Cancer,relapsed,"Size: 5cm, Grade: 3, ER/PR: Positive, HER2: Negative, Ki67: 100%","Neoadjuvant Chemotherapy, Radiotherapy",,3,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,f
159,19,Female,Breast Cancer,relapsed,"Size: 6cm, Grade: 2, ER/PR: Negative, HER2: Positive, Ki67: 37%","Targeted Therapy, Endocrine Therapy, ","PIK3CA, ",0,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
160,48,Female,Breast Cancer,relapsed,"Size: 5cm, Grade: 3, ER/PR: Negative, HER2: Negative, Ki67: 84%",Radiotherapy,"BRCA2, ",2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
161,57,Male,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 1, ER/PR: Positive, HER2: Negative, Ki67: 49%","Neoadjuvant Chemotherapy, Radiotherapy","BRCA1, ",2,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
162,78,Female,Breast Cancer,relapsed,"Size: 4cm, Grade: 2, ER/PR: Positive, HER2: Negative, Ki67: 17%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Radiotherapy","PIK3CA, ",2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
163,27,Female,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 1, ER/PR: Negative, HER2: Negative, Ki67: 11%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, Radiotherapy","BRCA2, ",0,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
164,64,Female,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 1, ER/PR: Negative, HER2: Positive, Ki67: 3%","Targeted Therapy, ",,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
165,69,Female,Breast Cancer,newly diagnosed,"Size: 5cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 90%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, ",,1,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
166,25,Female,Breast Cancer,relapsed,"Size: 6cm, Grade: 2, ER/PR: Positive, HER2: Negative, Ki67: 67%","Neoadjuvant Chemotherapy, ",,2,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
167,36,Female,Breast Cancer,relapsed,"Size: 6cm, Grade: 1, ER/PR: Positive, HER2: Negative, Ki67: 11%","Neoadjuvant Chemotherapy, Targeted Therapy, Radiotherapy","BRCA2, ",2,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
168,50,Female,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 1, ER/PR: Positive, HER2: Positive, Ki67: 20%","Targeted Therapy, Endocrine Therapy, ",,2,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
169,70,Female,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 70%","Neoadjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, ",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
170,31,Female,Breast Cancer,newly diagnosed,"Size: 5cm, Grade: 2, ER/PR: Positive, HER2: Negative, Ki67: 24%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, Radiotherapy",,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
171,77,Female,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 22%","Adjuvant Chemotherapy, Endocrine Therapy, Radiotherapy","PIK3CA, ",3,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
172,23,Female,Breast Cancer,newly diagnosed,"Size: 5cm, Grade: 2, ER/PR: Positive, HER2: Negative, Ki67: 92%","Neoadjuvant Chemotherapy, ",,1,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,f
173,57,Female,Breast Cancer,relapsed,"Size: 2cm, Grade: 3, ER/PR: Negative, HER2: Negative, Ki67: 95%","Neoadjuvant Chemotherapy, Endocrine Therapy, ",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
174,35,Female,Breast Cancer,relapsed,"Size: 3cm, Grade: 2, ER/PR: Positive, HER2: Negative, Ki67: 51%","Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, ",,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
175,56,Female,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 3, ER/PR: Positive, HER2: Negative, Ki67: 68%",Radiotherapy,,1,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
176,23,Female,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 3, ER/PR: Positive, HER2: Positive, Ki67: 65%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Radiotherapy",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,f
177,36,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 2, ER/PR: Positive, HER2: Negative, Ki67: 27%","Adjuvant Chemotherapy, Targeted Therapy, ","BRCA1, ",2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
178,35,Female,Breast Cancer,relapsed,"Size: 3cm, Grade: 3, ER/PR: Positive, HER2: Negative, Ki67: 58%","Neoadjuvant Chemotherapy, Endocrine Therapy, ",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
179,73,Female,Breast Cancer,relapsed,"Size: 1cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 52%","Targeted Therapy, Endocrine Therapy, ",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
180,52,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 4, ER/PR: Negative, HER2: Positive, Ki67: 63%","Adjuvant Chemotherapy, Endocrine Therapy, ",,2,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
181,53,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 3, ER/PR: Positive, HER2: Positive, Ki67: 1%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Endocrine Therapy, ",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
182,56,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 3, ER/PR: Negative, HER2: Positive, Ki67: 77%",,,3,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
183,35,Female,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 2, ER/PR: Positive, HER2: Negative, Ki67: 6%","Targeted Therapy, Radiotherapy",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
184,66,Female,Breast Cancer,relapsed,"Size: 6cm, Grade: 1, ER/PR: Positive, HER2: Negative, Ki67: 96%","Neoadjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, ","PIK3CA, ",1,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
185,46,Female,Breast Cancer,relapsed,"Size: 1cm, Grade: 1, ER/PR: Positive, HER2: Negative, Ki67: 80%","Neoadjuvant Chemotherapy, Targeted Therapy, Radiotherapy","BRCA2, ",2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
186,20,Female,Breast Cancer,relapsed,"Size: 4cm, Grade: 2, ER/PR: Positive, HER2: Negative, Ki67: 5%","Targeted Therapy, Radiotherapy","PIK3CA, ",3,Normal,f,Risk features,Comorbidities,Previous cancer history,Pregnant/Breastfeeding,t
187,33,Female,Breast Cancer,relapsed,"Size: 5cm, Grade: 3, ER/PR: Negative, HER2: Positive, Ki67: 27%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, ",,2,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
188,50,Female,Breast Cancer,newly diagnosed,"Size: 6cm, Grade: 2, ER/PR: Negative, HER2: Positive, Ki67: 26%","Neoadjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, ",TP53,0,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
189,38,Female,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 3, ER/PR: Positive, HER2: Negative, Ki67: 54%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Radiotherapy",,3,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
190,45,Female,Breast Cancer,newly diagnosed,"Size: 5cm, Grade: 2, ER/PR: Positive, HER2: Negative, Ki67: 8%",Radiotherapy,,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
191,61,Female,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 93%","Targeted Therapy, Radiotherapy",,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
192,47,Female,Breast Cancer,relapsed,"Size: 2cm, Grade: 3, ER/PR: Positive, HER2: Negative, Ki67: 85%","Targeted Therapy, Endocrine Therapy, ",,0,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,f
193,18,Female,Breast Cancer,relapsed,"Size: 3cm, Grade: 1, ER/PR: Negative, HER2: Negative, Ki67: 10%","Adjuvant Chemotherapy, ","BRCA1, ",1,Impaired,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
194,71,Female,Breast Cancer,relapsed,"Size: 4cm, Grade: 1, ER/PR: Negative, HER2: Negative, Ki67: 47%","Targeted Therapy, Radiotherapy",,2,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
195,48,Female,Breast Cancer,relapsed,"Size: 2cm, Grade: 3, ER/PR: Negative, HER2: Positive, Ki67: 82%","Neoadjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, Radiotherapy","BRCA1, ",1,Impaired,f,Risk features,Comorbidities,Previous cancer history,Pregnant/Breastfeeding,t
196,33,Female,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 3, ER/PR: Negative, HER2: Positive, Ki67: 84%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, ","BRCA1, TP53",1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,f
197,76,Female,Breast Cancer,relapsed,"Size: 6cm, Grade: 3, ER/PR: Positive, HER2: Positive, Ki67: 25%","Endocrine Therapy, Radiotherapy",,2,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
198,19,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 3, ER/PR: Negative, HER2: Negative, Ki67: 13%","Adjuvant Chemotherapy, Radiotherapy",,3,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
199,53,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 4, ER/PR: Negative, HER2: Negative, Ki67: 11%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, ",,3,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
200,68,Female,Breast Cancer,relapsed,"Size: 5cm, Grade: 3, ER/PR: Positive, HER2: Positive, Ki67: 32%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Endocrine Therapy, Radiotherapy",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
201,76,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 1, ER/PR: Negative, HER2: Negative, Ki67: 64%","Neoadjuvant Chemotherapy, Targeted Therapy, Radiotherapy",TP53,3,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
202,35,Male,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 3, ER/PR: Negative, HER2: Negative, Ki67: 81%","Targeted Therapy, Radiotherapy","PIK3CA, ",2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
203,43,Female,Breast Cancer,relapsed,"Size: 3cm, Grade: 4, ER/PR: Positive, HER2: Negative, Ki67: 17%","Adjuvant Chemotherapy, ","PIK3CA, ",2,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
204,74,Female,Breast Cancer,relapsed,"Size: 1cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 53%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, ",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
205,32,Female,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 2, ER/PR: Positive, HER2: Negative, Ki67: 58%","Neoadjuvant Chemotherapy, ",,3,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,f
206,24,Female,Breast Cancer,relapsed,"Size: 4cm, Grade: 1, ER/PR: Positive, HER2: Negative, Ki67: 51%","Neoadjuvant Chemotherapy, Endocrine Therapy, Radiotherapy",,1,Impaired,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
207,67,Male,Breast Cancer,newly diagnosed,"Size: 5cm, Grade: 2, ER/PR: Positive, HER2: Positive, Ki67: 53%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, Radiotherapy","BRCA2, ",2,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
208,46,Female,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 4, ER/PR: Negative, HER2: Positive, Ki67: 33%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, ",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
209,71,Male,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 3, ER/PR: Negative, HER2: Negative, Ki67: 19%","Endocrine Therapy, Radiotherapy",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
210,69,Female,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 3, ER/PR: Positive, HER2: Negative, Ki67: 61%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, ","BRCA1, BRCA2, ",3,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
211,57,Female,Breast Cancer,relapsed,"Size: 1cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 13%","Targeted Therapy, Endocrine Therapy, ","BRCA1, ",3,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
212,50,Female,Breast Cancer,relapsed,"Size: 4cm, Grade: 1, ER/PR: Positive, HER2: Negative, Ki67: 99%",Radiotherapy,"BRCA2, ",1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
213,74,Female,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 3, ER/PR: Negative, HER2: Negative, Ki67: 96%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, ",,1,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,f
214,62,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 56%","Neoadjuvant Chemotherapy, Targeted Therapy, Radiotherapy",,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
215,24,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 55%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, Radiotherapy",,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
216,28,Male,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 2, ER/PR: Positive, HER2: Negative, Ki67: 24%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, Radiotherapy",,1,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
217,64,Male,Breast Cancer,relapsed,"Size: 5cm, Grade: 2, ER/PR: Positive, HER2: Negative, Ki67: 59%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, Radiotherapy",TP53,0,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
218,61,Female,Breast Cancer,newly diagnosed,"Size: 1cm, Grade: 3, ER/PR: Positive, HER2: Positive, Ki67: 26%","Neoadjuvant Chemotherapy, Targeted Therapy, Radiotherapy",,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
219,20,Female,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 2, ER/PR: Positive, HER2: Positive, Ki67: 80%","Adjuvant Chemotherapy, Endocrine Therapy, Radiotherapy",,0,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
220,46,Female,Breast Cancer,newly diagnosed,"Size: 1cm, Grade: 3, ER/PR: Positive, HER2: Negative, Ki67: 36%","Adjuvant Chemotherapy, Endocrine Therapy, ",,1,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
221,71,Female,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 1, ER/PR: Positive, HER2: Negative, Ki67: 74%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, ",,3,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
222,40,Female,Breast Cancer,relapsed,"Size: 1cm, Grade: 3, ER/PR: Negative, HER2: Negative, Ki67: 78%","Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, ",,2,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
223,49,Male,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 10%","Neoadjuvant Chemotherapy, ",,2,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
224,42,Female,Breast Cancer,relapsed,"Size: 6cm, Grade: 1, ER/PR: Negative, HER2: Positive, Ki67: 71%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Radiotherapy",,0,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
225,45,Female,Breast Cancer,relapsed,"Size: 3cm, Grade: 3, ER/PR: Positive, HER2: Negative, Ki67: 67%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Radiotherapy",,0,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
226,24,Female,Breast Cancer,relapsed,"Size: 6cm, Grade: 1, ER/PR: Positive, HER2: Negative, Ki67: 80%","Adjuvant Chemotherapy, Targeted Therapy, ",,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
227,44,Female,Breast Cancer,relapsed,"Size: 5cm, Grade: 2, ER/PR: Negative, HER2: Positive, Ki67: 28%","Endocrine Therapy, ",,0,Normal,f,Risk features,Comorbidities,Previous cancer history,Pregnant/Breastfeeding,t
228,74,Female,Breast Cancer,relapsed,"Size: 2cm, Grade: 2, ER/PR: Positive, HER2: Positive, Ki67: 83%","Neoadjuvant Chemotherapy, Targeted Therapy, Radiotherapy",,0,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
229,58,Female,Breast Cancer,relapsed,"Size: 6cm, Grade: 2, ER/PR: Positive, HER2: Negative, Ki67: 36%","Adjuvant Chemotherapy, Targeted Therapy, Radiotherapy","BRCA2, ",1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
230,20,Female,Breast Cancer,relapsed,"Size: 5cm, Grade: 4, ER/PR: Positive, HER2: Positive, Ki67: 2%","Endocrine Therapy, ","PIK3CA, BRCA1, BRCA2, ",2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
231,20,Female,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 11%","Adjuvant Chemotherapy, Targeted Therapy, ",,1,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
232,77,Female,Breast Cancer,relapsed,"Size: 4cm, Grade: 4, ER/PR: Negative, HER2: Negative, Ki67: 66%","Neoadjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, ",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
233,62,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 2, ER/PR: Negative, HER2: Positive, Ki67: 3%",Radiotherapy,"BRCA1, ",1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
234,46,Female,Breast Cancer,relapsed,"Size: 2cm, Grade: 3, ER/PR: Positive, HER2: Negative, Ki67: 44%","Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, ",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,f
235,74,Female,Breast Cancer,newly diagnosed,"Size: 1cm, Grade: 1, ER/PR: Negative, HER2: Positive, Ki67: 49%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, ",,0,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,f
236,66,Female,Breast Cancer,relapsed,"Size: 3cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 23%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, ",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
237,36,Male,Breast Cancer,newly diagnosed,"Size: 1cm, Grade: 3, ER/PR: Positive, HER2: Positive, Ki67: 79%","Adjuvant Chemotherapy, Targeted Therapy, Radiotherapy",,2,Impaired,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,f
238,78,Male,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 2, ER/PR: Negative, HER2: Positive, Ki67: 75%","Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, Radiotherapy","PIK3CA, BRCA2, ",3,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
239,28,Female,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 1, ER/PR: Positive, HER2: Negative, Ki67: 20%","Neoadjuvant Chemotherapy, Targeted Therapy, ",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
240,24,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 2, ER/PR: Positive, HER2: Positive, Ki67: 24%","Neoadjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, ",,2,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
241,53,Female,Breast Cancer,relapsed,"Size: 4cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 17%","Targeted Therapy, Radiotherapy",,2,Impaired,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
242,60,Female,Breast Cancer,relapsed,"Size: 1cm, Grade: 1, ER/PR: Negative, HER2: Negative, Ki67: 66%",Radiotherapy,,3,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
243,27,Female,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 3, ER/PR: Positive, HER2: Positive, Ki67: 30%","Neoadjuvant Chemotherapy, Endocrine Therapy, Radiotherapy",,1,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
244,49,Male,Breast Cancer,relapsed,"Size: 2cm, Grade: 4, ER/PR: Positive, HER2: Negative, Ki67: 50%","Targeted Therapy, Endocrine Therapy, Radiotherapy","BRCA2, ",1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
245,66,Female,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 1, ER/PR: Negative, HER2: Negative, Ki67: 49%","Neoadjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, Radiotherapy",,1,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
246,33,Female,Breast Cancer,newly diagnosed,"Size: 6cm, Grade: 3, ER/PR: Negative, HER2: Positive, Ki67: 51%","Adjuvant Chemotherapy, Targeted Therapy, Radiotherapy",,0,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
247,71,Female,Breast Cancer,newly diagnosed,"Size: 5cm, Grade: 1, ER/PR: Positive, HER2: Negative, Ki67: 82%","Neoadjuvant Chemotherapy, ",,3,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
248,30,Female,Breast Cancer,relapsed,"Size: 6cm, Grade: 4, ER/PR: Positive, HER2: Negative, Ki67: 56%","Adjuvant Chemotherapy, ",TP53,0,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
249,44,Female,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 31%","Targeted Therapy, ",,1,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
250,29,Female,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 3, ER/PR: Negative, HER2: Negative, Ki67: 1%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, ",,1,Impaired,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,f
251,50,Female,Breast Cancer,relapsed,"Size: 5cm, Grade: 1, ER/PR: Negative, HER2: Negative, Ki67: 82%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Radiotherapy",,1,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
252,35,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 1, ER/PR: Positive, HER2: Negative, Ki67: 81%","Neoadjuvant Chemotherapy, Radiotherapy",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
253,73,Female,Breast Cancer,newly diagnosed,"Size: 5cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 7%","Neoadjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, Radiotherapy","PIK3CA, ",3,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
254,46,Female,Breast Cancer,relapsed,"Size: 5cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 8%","Targeted Therapy, Radiotherapy",,3,Impaired,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
255,43,Female,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 3, ER/PR: Negative, HER2: Negative, Ki67: 72%","Neoadjuvant Chemotherapy, Targeted Therapy, ",,3,Impaired,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,f
256,66,Female,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 3, ER/PR: Positive, HER2: Positive, Ki67: 19%","Neoadjuvant Chemotherapy, Targeted Therapy, ",TP53,1,Impaired,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,f
257,76,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 3, ER/PR: Negative, HER2: Negative, Ki67: 36%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, ","BRCA2, ",1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
258,27,Female,Breast Cancer,newly diagnosed,"Size: 6cm, Grade: 4, ER/PR: Positive, HER2: Positive, Ki67: 68%","Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, Radiotherapy","PIK3CA, ",3,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
259,37,Female,Breast Cancer,relapsed,"Size: 2cm, Grade: 4, ER/PR: Positive, HER2: Negative, Ki67: 31%","Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, ",TP53,1,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,f
260,36,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 2, ER/PR: Positive, HER2: Negative, Ki67: 87%","Adjuvant Chemotherapy, Targeted Therapy, Radiotherapy",TP53,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
261,24,Male,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 2, ER/PR: Positive, HER2: Negative, Ki67: 84%","Adjuvant Chemotherapy, Endocrine Therapy, ",TP53,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,f
262,23,Female,Breast Cancer,relapsed,"Size: 3cm, Grade: 2, ER/PR: Negative, HER2: Positive, Ki67: 31%","Neoadjuvant Chemotherapy, Radiotherapy",,2,Impaired,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
263,46,Female,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 4, ER/PR: Negative, HER2: Negative, Ki67: 99%","Neoadjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, Radiotherapy",,1,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
264,78,Female,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 4, ER/PR: Negative, HER2: Negative, Ki67: 1%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Radiotherapy","BRCA2, ",3,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,f
265,31,Female,Breast Cancer,relapsed,"Size: 2cm, Grade: 1, ER/PR: Positive, HER2: Negative, Ki67: 38%",Radiotherapy,"PIK3CA, ",2,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
266,69,Female,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 28%","Adjuvant Chemotherapy, Targeted Therapy, Radiotherapy",,3,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
267,23,Female,Breast Cancer,newly diagnosed,"Size: 5cm, Grade: 4, ER/PR: Negative, HER2: Negative, Ki67: 51%","Adjuvant Chemotherapy, Targeted Therapy, ",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
268,61,Female,Breast Cancer,newly diagnosed,"Size: 5cm, Grade: 3, ER/PR: Positive, HER2: Negative, Ki67: 32%",Radiotherapy,,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
269,61,Female,Breast Cancer,newly diagnosed,"Size: 1cm, Grade: 3, ER/PR: Positive, HER2: Negative, Ki67: 12%","Adjuvant Chemotherapy, Radiotherapy",TP53,2,Impaired,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,f
270,41,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 2, ER/PR: Negative, HER2: Positive, Ki67: 4%","Neoadjuvant Chemotherapy, ","BRCA1, ",0,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
271,33,Female,Breast Cancer,relapsed,"Size: 3cm, Grade: 2, ER/PR: Positive, HER2: Positive, Ki67: 78%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, ",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
272,46,Female,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 2, ER/PR: Positive, HER2: Negative, Ki67: 51%","Adjuvant Chemotherapy, ",,3,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
273,51,Female,Breast Cancer,relapsed,"Size: 3cm, Grade: 3, ER/PR: Positive, HER2: Positive, Ki67: 90%","Neoadjuvant Chemotherapy, ",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
274,39,Female,Breast Cancer,newly diagnosed,"Size: 1cm, Grade: 2, ER/PR: Positive, HER2: Negative, Ki67: 20%","Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, ","BRCA1, ",3,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
275,53,Female,Breast Cancer,newly diagnosed,"Size: 6cm, Grade: 4, ER/PR: Negative, HER2: Positive, Ki67: 64%","Neoadjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, ",,2,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,f
276,59,Female,Breast Cancer,relapsed,"Size: 4cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 14%","Adjuvant Chemotherapy, Targeted Therapy, ",,1,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
277,75,Female,Breast Cancer,relapsed,"Size: 1cm, Grade: 2, ER/PR: Positive, HER2: Positive, Ki67: 27%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, ","BRCA1, ",3,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
278,53,Female,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 60%","Adjuvant Chemotherapy, Endocrine Therapy, Radiotherapy","BRCA2, ",3,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
279,44,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 39%","Targeted Therapy, Endocrine Therapy, ",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
280,49,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 1, ER/PR: Positive, HER2: Positive, Ki67: 77%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, ",,1,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,f
281,20,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 3, ER/PR: Negative, HER2: Negative, Ki67: 83%","Neoadjuvant Chemotherapy, Endocrine Therapy, Radiotherapy",,0,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
282,26,Female,Breast Cancer,newly diagnosed,"Size: 5cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 28%",Radiotherapy,,3,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
283,45,Female,Breast Cancer,newly diagnosed,"Size: 1cm, Grade: 3, ER/PR: Positive, HER2: Negative, Ki67: 39%","Adjuvant Chemotherapy, Endocrine Therapy, ",,0,Impaired,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
284,67,Female,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 2, ER/PR: Positive, HER2: Negative, Ki67: 91%","Neoadjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, ",,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
285,34,Female,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 77%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Endocrine Therapy, Radiotherapy",,3,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
286,38,Female,Breast Cancer,newly diagnosed,"Size: 5cm, Grade: 1, ER/PR: Negative, HER2: Negative, Ki67: 12%","Endocrine Therapy, Radiotherapy","BRCA1, ",2,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
287,47,Female,Breast Cancer,newly diagnosed,"Size: 5cm, Grade: 2, ER/PR: Positive, HER2: Positive, Ki67: 18%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Endocrine Therapy, Radiotherapy",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
288,72,Female,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 0%","Targeted Therapy, Radiotherapy",,3,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
289,30,Female,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 3, ER/PR: Negative, HER2: Positive, Ki67: 84%","Adjuvant Chemotherapy, Radiotherapy",,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
290,53,Female,Breast Cancer,relapsed,"Size: 5cm, Grade: 3, ER/PR: Negative, HER2: Positive, Ki67: 28%","Targeted Therapy, Radiotherapy",,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
291,77,Female,Breast Cancer,newly diagnosed,"Size: 6cm, Grade: 2, ER/PR: Positive, HER2: Negative, Ki67: 17%","Neoadjuvant Chemotherapy, Endocrine Therapy, ",,0,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
292,24,Female,Breast Cancer,newly diagnosed,"Size: 1cm, Grade: 3, ER/PR: Negative, HER2: Negative, Ki67: 18%","Neoadjuvant Chemotherapy, Targeted Therapy, ",TP53,1,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
293,48,Male,Breast Cancer,newly diagnosed,"Size: 1cm, Grade: 4, ER/PR: Negative, HER2: Negative, Ki67: 72%","Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, ",,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
294,51,Female,Breast Cancer,relapsed,"Size: 2cm, Grade: 4, ER/PR: Positive, HER2: Negative, Ki67: 18%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, Radiotherapy",,3,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,f
295,18,Female,Breast Cancer,newly diagnosed,"Size: 5cm, Grade: 2, ER/PR: Negative, HER2: Positive, Ki67: 9%","Neoadjuvant Chemotherapy, Targeted Therapy, Radiotherapy",,0,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
296,21,Female,Breast Cancer,newly diagnosed,"Size: 6cm, Grade: 3, ER/PR: Negative, HER2: Positive, Ki67: 49%","Neoadjuvant Chemotherapy, Radiotherapy",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Pregnant/Breastfeeding,f
297,55,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 50%","Adjuvant Chemotherapy, Targeted Therapy, ",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
298,77,Female,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 67%","Targeted Therapy, ",,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
299,67,Female,Breast Cancer,relapsed,"Size: 2cm, Grade: 3, ER/PR: Negative, HER2: Negative, Ki67: 80%","Adjuvant Chemotherapy, Targeted Therapy, ",,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
300,31,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 2, ER/PR: Negative, HER2: Positive, Ki67: 92%","Targeted Therapy, ","BRCA1, ",1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
301,45,Female,Breast Cancer,newly diagnosed,"Size: 5cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 11%","Adjuvant Chemotherapy, ",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
302,78,Female,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 3, ER/PR: Negative, HER2: Positive, Ki67: 11%","Adjuvant Chemotherapy, Targeted Therapy, ","BRCA1, BRCA2, ",1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
303,78,Female,Breast Cancer,relapsed,"Size: 5cm, Grade: 1, ER/PR: Negative, HER2: Negative, Ki67: 93%",,"BRCA1, ",1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
304,25,Female,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 3, ER/PR: Positive, HER2: Negative, Ki67: 97%","Endocrine Therapy, ",TP53,0,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
305,46,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 1, ER/PR: Positive, HER2: Positive, Ki67: 66%","Adjuvant Chemotherapy, Radiotherapy","PIK3CA, ",2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
306,77,Female,Breast Cancer,relapsed,"Size: 3cm, Grade: 3, ER/PR: Positive, HER2: Negative, Ki67: 26%","Targeted Therapy, ",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
307,51,Male,Breast Cancer,newly diagnosed,"Size: 1cm, Grade: 3, ER/PR: Negative, HER2: Negative, Ki67: 5%","Targeted Therapy, ",,3,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
308,36,Female,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 3, ER/PR: Positive, HER2: Negative, Ki67: 73%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, Radiotherapy","BRCA2, ",1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
309,47,Male,Breast Cancer,relapsed,"Size: 2cm, Grade: 2, ER/PR: Positive, HER2: Negative, Ki67: 12%",,,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
310,45,Female,Breast Cancer,newly diagnosed,"Size: 1cm, Grade: 2, ER/PR: Negative, HER2: Positive, Ki67: 5%",Radiotherapy,,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
311,66,Female,Breast Cancer,relapsed,"Size: 1cm, Grade: 4, ER/PR: Negative, HER2: Negative, Ki67: 68%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Radiotherapy",,2,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
312,79,Male,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 2, ER/PR: Positive, HER2: Negative, Ki67: 29%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Endocrine Therapy, Radiotherapy",,2,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
313,28,Female,Breast Cancer,relapsed,"Size: 2cm, Grade: 3, ER/PR: Negative, HER2: Positive, Ki67: 2%","Neoadjuvant Chemotherapy, Targeted Therapy, ",TP53,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
314,79,Male,Breast Cancer,relapsed,"Size: 6cm, Grade: 2, ER/PR: Negative, HER2: Positive, Ki67: 11%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, ",,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
315,36,Female,Breast Cancer,newly diagnosed,"Size: 5cm, Grade: 3, ER/PR: Negative, HER2: Negative, Ki67: 65%","Neoadjuvant Chemotherapy, Radiotherapy",,0,Normal,f,Risk features,Comorbidities,Previous cancer history,Pregnant/Breastfeeding,t
316,59,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 1, ER/PR: Negative, HER2: Positive, Ki67: 59%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, Radiotherapy",,3,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,f
317,68,Female,Breast Cancer,newly diagnosed,"Size: 6cm, Grade: 3, ER/PR: Negative, HER2: Negative, Ki67: 41%","Neoadjuvant Chemotherapy, Endocrine Therapy, Radiotherapy",,3,Normal,f,Risk features,Comorbidities,Previous cancer history,Pregnant/Breastfeeding,t
318,62,Male,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 3, ER/PR: Negative, HER2: Negative, Ki67: 18%","Endocrine Therapy, Radiotherapy",,0,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
319,77,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 3, ER/PR: Positive, HER2: Positive, Ki67: 56%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, ","BRCA1, TP53",1,Normal,t,Risk features,Comorbidities,Previous cancer history,Pregnant/Breastfeeding,t
320,77,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 2, ER/PR: Positive, HER2: Negative, Ki67: 1%","Neoadjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, Radiotherapy","BRCA2, ",2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,f
321,72,Female,Breast Cancer,newly diagnosed,"Size: 5cm, Grade: 3, ER/PR: Negative, HER2: Negative, Ki67: 22%","Neoadjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, ","PIK3CA, ",0,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
322,59,Female,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 3, ER/PR: Negative, HER2: Negative, Ki67: 39%","Adjuvant Chemotherapy, ",,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
323,57,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 1, ER/PR: Positive, HER2: Negative, Ki67: 33%","Neoadjuvant Chemotherapy, Endocrine Therapy, ","BRCA2, ",3,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
324,31,Female,Breast Cancer,relapsed,"Size: 3cm, Grade: 3, ER/PR: Positive, HER2: Positive, Ki67: 7%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Radiotherapy","BRCA1, BRCA2, ",2,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
325,80,Female,Breast Cancer,newly diagnosed,"Size: 1cm, Grade: 1, ER/PR: Negative, HER2: Positive, Ki67: 83%","Neoadjuvant Chemotherapy, Targeted Therapy, Radiotherapy","BRCA2, ",2,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
326,49,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 56%","Adjuvant Chemotherapy, Radiotherapy",,0,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,f
327,22,Male,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 72%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, ",,2,Impaired,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
328,80,Female,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 1, ER/PR: Negative, HER2: Negative, Ki67: 67%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, ","PIK3CA, ",3,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
329,18,Female,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 3, ER/PR: Negative, HER2: Negative, Ki67: 28%","Neoadjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, ","BRCA2, ",0,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
330,52,Female,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 4, ER/PR: Positive, HER2: Negative, Ki67: 29%","Neoadjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, Radiotherapy",,3,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
331,52,Female,Breast Cancer,relapsed,"Size: 2cm, Grade: 3, ER/PR: Positive, HER2: Negative, Ki67: 34%","Targeted Therapy, Radiotherapy",,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
332,50,Female,Breast Cancer,relapsed,"Size: 2cm, Grade: 3, ER/PR: Negative, HER2: Negative, Ki67: 34%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Endocrine Therapy, Radiotherapy","PIK3CA, ",1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
333,68,Female,Breast Cancer,newly diagnosed,"Size: 1cm, Grade: 3, ER/PR: Positive, HER2: Positive, Ki67: 87%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, Radiotherapy",,0,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
334,79,Female,Breast Cancer,newly diagnosed,"Size: 5cm, Grade: 3, ER/PR: Negative, HER2: Negative, Ki67: 43%","Adjuvant Chemotherapy, Targeted Therapy, ",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
335,57,Female,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 2, ER/PR: Negative, HER2: Positive, Ki67: 97%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Endocrine Therapy, ","BRCA1, ",2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
336,24,Female,Breast Cancer,relapsed,"Size: 3cm, Grade: 2, ER/PR: Positive, HER2: Positive, Ki67: 39%","Neoadjuvant Chemotherapy, Targeted Therapy, Radiotherapy","PIK3CA, TP53",1,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
337,37,Female,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 4, ER/PR: Negative, HER2: Negative, Ki67: 5%","Adjuvant Chemotherapy, Endocrine Therapy, Radiotherapy","BRCA1, ",1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,f
338,61,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 2, ER/PR: Positive, HER2: Negative, Ki67: 20%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Endocrine Therapy, Radiotherapy",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
339,66,Female,Breast Cancer,relapsed,"Size: 2cm, Grade: 3, ER/PR: Negative, HER2: Negative, Ki67: 10%","Neoadjuvant Chemotherapy, ","PIK3CA, ",2,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
340,31,Female,Breast Cancer,newly diagnosed,"Size: 5cm, Grade: 3, ER/PR: Negative, HER2: Negative, Ki67: 82%","Neoadjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, Radiotherapy",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
341,21,Female,Breast Cancer,newly diagnosed,"Size: 1cm, Grade: 3, ER/PR: Positive, HER2: Positive, Ki67: 3%","Adjuvant Chemotherapy, Targeted Therapy, ",,1,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
342,54,Female,Breast Cancer,newly diagnosed,"Size: 6cm, Grade: 1, ER/PR: Negative, HER2: Negative, Ki67: 96%",,"BRCA2, ",1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
343,44,Female,Breast Cancer,relapsed,"Size: 2cm, Grade: 4, ER/PR: Negative, HER2: Negative, Ki67: 16%","Neoadjuvant Chemotherapy, Radiotherapy",,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
344,31,Male,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 4, ER/PR: Negative, HER2: Positive, Ki67: 25%","Endocrine Therapy, ",,2,Impaired,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
345,30,Female,Breast Cancer,newly diagnosed,"Size: 5cm, Grade: 3, ER/PR: Negative, HER2: Negative, Ki67: 37%","Targeted Therapy, Radiotherapy",,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
346,40,Female,Breast Cancer,newly diagnosed,"Size: 1cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 31%",Radiotherapy,"BRCA1, ",3,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
347,48,Female,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 1, ER/PR: Negative, HER2: Negative, Ki67: 23%","Neoadjuvant Chemotherapy, Radiotherapy","BRCA1, ",2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
348,44,Male,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 2, ER/PR: Positive, HER2: Positive, Ki67: 52%","Adjuvant Chemotherapy, Radiotherapy",,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,f
349,28,Female,Breast Cancer,relapsed,"Size: 3cm, Grade: 2, ER/PR: Positive, HER2: Positive, Ki67: 42%","Neoadjuvant Chemotherapy, Targeted Therapy, ",,1,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
350,66,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 40%","Endocrine Therapy, ",,2,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
351,31,Female,Breast Cancer,relapsed,"Size: 6cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 99%","Adjuvant Chemotherapy, Endocrine Therapy, ",,0,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
352,19,Female,Breast Cancer,relapsed,"Size: 2cm, Grade: 2, ER/PR: Positive, HER2: Negative, Ki67: 68%","Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, ",,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,f
353,43,Male,Breast Cancer,newly diagnosed,"Size: 5cm, Grade: 4, ER/PR: Positive, HER2: Negative, Ki67: 19%","Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, Radiotherapy",,0,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
354,27,Female,Breast Cancer,relapsed,"Size: 2cm, Grade: 1, ER/PR: Negative, HER2: Positive, Ki67: 88%","Neoadjuvant Chemotherapy, Endocrine Therapy, Radiotherapy",,1,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
355,36,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 2%","Adjuvant Chemotherapy, Targeted Therapy, Radiotherapy",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
356,20,Female,Breast Cancer,newly diagnosed,"Size: 6cm, Grade: 2, ER/PR: Negative, HER2: Positive, Ki67: 86%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, ",,1,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
357,78,Male,Breast Cancer,relapsed,"Size: 5cm, Grade: 1, ER/PR: Positive, HER2: Negative, Ki67: 62%","Adjuvant Chemotherapy, Radiotherapy","BRCA1, BRCA2, ",2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
358,73,Female,Breast Cancer,relapsed,"Size: 4cm, Grade: 1, ER/PR: Positive, HER2: Negative, Ki67: 27%","Adjuvant Chemotherapy, Radiotherapy","PIK3CA, TP53",1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
359,52,Female,Breast Cancer,relapsed,"Size: 2cm, Grade: 2, ER/PR: Positive, HER2: Negative, Ki67: 46%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, ","BRCA1, BRCA2, ",2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
360,44,Female,Breast Cancer,relapsed,"Size: 6cm, Grade: 4, ER/PR: Positive, HER2: Negative, Ki67: 65%","Neoadjuvant Chemotherapy, Targeted Therapy, Radiotherapy","BRCA2, ",2,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
361,42,Female,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 3, ER/PR: Positive, HER2: Negative, Ki67: 28%","Endocrine Therapy, Radiotherapy",,0,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
362,65,Female,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 3, ER/PR: Positive, HER2: Negative, Ki67: 6%","Neoadjuvant Chemotherapy, ","BRCA1, ",3,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
363,36,Female,Breast Cancer,newly diagnosed,"Size: 5cm, Grade: 4, ER/PR: Positive, HER2: Negative, Ki67: 79%","Adjuvant Chemotherapy, Targeted Therapy, ","PIK3CA, TP53",1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
364,51,Female,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 4, ER/PR: Positive, HER2: Positive, Ki67: 11%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Endocrine Therapy, ",,3,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
365,36,Female,Breast Cancer,relapsed,"Size: 3cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 99%",Radiotherapy,,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
366,48,Female,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 1, ER/PR: Negative, HER2: Negative, Ki67: 35%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Radiotherapy","BRCA1, ",1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
367,29,Female,Breast Cancer,relapsed,"Size: 2cm, Grade: 1, ER/PR: Negative, HER2: Negative, Ki67: 71%",Radiotherapy,,3,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
368,80,Female,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 2, ER/PR: Positive, HER2: Negative, Ki67: 74%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Endocrine Therapy, ",TP53,3,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
369,30,Female,Breast Cancer,relapsed,"Size: 5cm, Grade: 3, ER/PR: Negative, HER2: Negative, Ki67: 65%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Endocrine Therapy, Radiotherapy",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Pregnant/Breastfeeding,f
370,59,Female,Breast Cancer,relapsed,"Size: 1cm, Grade: 2, ER/PR: Positive, HER2: Negative, Ki67: 68%","Adjuvant Chemotherapy, Endocrine Therapy, Radiotherapy","BRCA1, ",1,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
371,22,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 56%","Neoadjuvant Chemotherapy, Targeted Therapy, ","BRCA2, ",2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
372,35,Female,Breast Cancer,relapsed,"Size: 5cm, Grade: 3, ER/PR: Negative, HER2: Positive, Ki67: 88%","Adjuvant Chemotherapy, Targeted Therapy, ",,2,Normal,t,Risk features,Comorbidities,Previous cancer history,Pregnant/Breastfeeding,t
373,71,Female,Breast Cancer,newly diagnosed,"Size: 5cm, Grade: 2, ER/PR: Positive, HER2: Negative, Ki67: 25%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, Radiotherapy",,0,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,f
374,20,Female,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 38%","Targeted Therapy, ",,3,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
375,63,Female,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 81%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Radiotherapy",,3,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
376,33,Male,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 4, ER/PR: Positive, HER2: Negative, Ki67: 16%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, Radiotherapy","BRCA2, ",1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
377,69,Female,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 4, ER/PR: Negative, HER2: Negative, Ki67: 8%","Targeted Therapy, Endocrine Therapy, ",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
378,70,Female,Breast Cancer,newly diagnosed,"Size: 5cm, Grade: 4, ER/PR: Positive, HER2: Negative, Ki67: 90%","Neoadjuvant Chemotherapy, Radiotherapy","BRCA2, ",0,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,f
379,21,Female,Breast Cancer,relapsed,"Size: 6cm, Grade: 1, ER/PR: Positive, HER2: Positive, Ki67: 6%","Neoadjuvant Chemotherapy, Endocrine Therapy, ","PIK3CA, ",0,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
380,36,Male,Breast Cancer,newly diagnosed,"Size: 5cm, Grade: 2, ER/PR: Positive, HER2: Negative, Ki67: 47%","Adjuvant Chemotherapy, Targeted Therapy, ","PIK3CA, TP53",3,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
381,63,Female,Breast Cancer,relapsed,"Size: 1cm, Grade: 3, ER/PR: Positive, HER2: Positive, Ki67: 33%","Neoadjuvant Chemotherapy, Targeted Therapy, ",,0,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
382,59,Female,Breast Cancer,newly diagnosed,"Size: 5cm, Grade: 3, ER/PR: Positive, HER2: Negative, Ki67: 81%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Endocrine Therapy, ",,3,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
383,70,Female,Breast Cancer,newly diagnosed,"Size: 5cm, Grade: 3, ER/PR: Positive, HER2: Negative, Ki67: 85%","Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, ",,1,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
384,38,Female,Breast Cancer,relapsed,"Size: 1cm, Grade: 1, ER/PR: Positive, HER2: Negative, Ki67: 63%","Neoadjuvant Chemotherapy, ",,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
385,52,Female,Breast Cancer,newly diagnosed,"Size: 1cm, Grade: 4, ER/PR: Positive, HER2: Positive, Ki67: 9%","Neoadjuvant Chemotherapy, ","PIK3CA, ",1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
386,59,Female,Breast Cancer,newly diagnosed,"Size: 5cm, Grade: 4, ER/PR: Negative, HER2: Positive, Ki67: 34%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Endocrine Therapy, ","BRCA1, ",2,Impaired,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
387,55,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 4, ER/PR: Positive, HER2: Positive, Ki67: 50%","Adjuvant Chemotherapy, Endocrine Therapy, ",,2,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
388,69,Male,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 3, ER/PR: Positive, HER2: Positive, Ki67: 91%","Neoadjuvant Chemotherapy, Endocrine Therapy, ",,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
389,73,Male,Breast Cancer,newly diagnosed,"Size: 5cm, Grade: 3, ER/PR: Negative, HER2: Positive, Ki67: 84%","Targeted Therapy, ",,1,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
390,20,Female,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 4, ER/PR: Positive, HER2: Negative, Ki67: 45%","Targeted Therapy, Endocrine Therapy, ","BRCA1, ",2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
391,41,Female,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 2, ER/PR: Negative, HER2: Positive, Ki67: 21%","Neoadjuvant Chemotherapy, ",,0,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
392,19,Female,Breast Cancer,newly diagnosed,"Size: 5cm, Grade: 3, ER/PR: Negative, HER2: Negative, Ki67: 81%","Endocrine Therapy, ",,3,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
393,62,Female,Breast Cancer,relapsed,"Size: 5cm, Grade: 4, ER/PR: Positive, HER2: Negative, Ki67: 21%","Adjuvant Chemotherapy, ",,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
394,70,Female,Breast Cancer,relapsed,"Size: 3cm, Grade: 3, ER/PR: Negative, HER2: Negative, Ki67: 34%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, ",,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
395,54,Female,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 4, ER/PR: Positive, HER2: Positive, Ki67: 62%",,,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
396,74,Female,Breast Cancer,relapsed,"Size: 4cm, Grade: 3, ER/PR: Positive, HER2: Negative, Ki67: 75%","Endocrine Therapy, Radiotherapy",,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
397,38,Female,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 2, ER/PR: Negative, HER2: Positive, Ki67: 70%","Neoadjuvant Chemotherapy, Targeted Therapy, Radiotherapy",,3,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
398,65,Female,Breast Cancer,newly diagnosed,"Size: 1cm, Grade: 2, ER/PR: Positive, HER2: Negative, Ki67: 0%","Adjuvant Chemotherapy, Endocrine Therapy, Radiotherapy","BRCA1, ",2,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
399,22,Female,Breast Cancer,relapsed,"Size: 6cm, Grade: 3, ER/PR: Positive, HER2: Positive, Ki67: 6%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Endocrine Therapy, Radiotherapy",,1,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
400,29,Female,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 75%","Adjuvant Chemotherapy, ","BRCA1, BRCA2, ",2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
401,68,Female,Breast Cancer,newly diagnosed,"Size: 5cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 86%","Neoadjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, ",,0,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
402,32,Female,Breast Cancer,relapsed,"Size: 3cm, Grade: 3, ER/PR: Positive, HER2: Positive, Ki67: 19%","Adjuvant Chemotherapy, Radiotherapy",,0,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
403,52,Male,Breast Cancer,newly diagnosed,"Size: 5cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 8%",,,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
404,73,Female,Breast Cancer,relapsed,"Size: 5cm, Grade: 4, ER/PR: Negative, HER2: Positive, Ki67: 7%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, ","BRCA1, ",1,Impaired,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
405,63,Female,Breast Cancer,newly diagnosed,"Size: 5cm, Grade: 2, ER/PR: Positive, HER2: Negative, Ki67: 91%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, Radiotherapy",,0,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
406,26,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 1, ER/PR: Negative, HER2: Positive, Ki67: 55%","Adjuvant Chemotherapy, Endocrine Therapy, Radiotherapy",,3,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
407,27,Female,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 3, ER/PR: Positive, HER2: Negative, Ki67: 78%",Radiotherapy,,2,Impaired,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,f
408,38,Female,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 4, ER/PR: Negative, HER2: Positive, Ki67: 74%","Adjuvant Chemotherapy, Radiotherapy",,3,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
409,37,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 95%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Endocrine Therapy, Radiotherapy",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
410,65,Male,Breast Cancer,newly diagnosed,"Size: 1cm, Grade: 2, ER/PR: Positive, HER2: Positive, Ki67: 48%","Neoadjuvant Chemotherapy, Radiotherapy",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
411,39,Female,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 2, ER/PR: Positive, HER2: Negative, Ki67: 22%","Adjuvant Chemotherapy, Targeted Therapy, ",,1,Impaired,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
412,75,Female,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 1, ER/PR: Positive, HER2: Negative, Ki67: 54%","Targeted Therapy, ",,0,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
413,57,Female,Breast Cancer,relapsed,"Size: 2cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 6%","Endocrine Therapy, ",,2,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
414,49,Female,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 3, ER/PR: Negative, HER2: Positive, Ki67: 4%","Adjuvant Chemotherapy, Endocrine Therapy, ",,2,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
415,28,Female,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 1, ER/PR: Positive, HER2: Negative, Ki67: 44%","Targeted Therapy, ",,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
416,79,Female,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 3, ER/PR: Negative, HER2: Negative, Ki67: 9%","Neoadjuvant Chemotherapy, Endocrine Therapy, Radiotherapy","BRCA1, TP53",3,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
417,68,Female,Breast Cancer,newly diagnosed,"Size: 5cm, Grade: 3, ER/PR: Positive, HER2: Negative, Ki67: 71%","Neoadjuvant Chemotherapy, Targeted Therapy, ",,3,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
418,51,Female,Breast Cancer,relapsed,"Size: 5cm, Grade: 2, ER/PR: Positive, HER2: Negative, Ki67: 9%","Endocrine Therapy, ",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
419,60,Female,Breast Cancer,relapsed,"Size: 4cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 22%","Endocrine Therapy, ","BRCA2, ",1,Impaired,f,Risk features,Comorbidities,Previous cancer history,Pregnant/Breastfeeding,t
420,71,Female,Breast Cancer,relapsed,"Size: 3cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 53%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, ",,0,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
421,30,Female,Breast Cancer,newly diagnosed,"Size: 5cm, Grade: 1, ER/PR: Positive, HER2: Positive, Ki67: 8%","Targeted Therapy, Radiotherapy","PIK3CA, TP53",2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
422,59,Female,Breast Cancer,relapsed,"Size: 5cm, Grade: 2, ER/PR: Positive, HER2: Negative, Ki67: 6%",,,2,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
423,38,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 66%","Adjuvant Chemotherapy, ",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
424,32,Male,Breast Cancer,relapsed,"Size: 6cm, Grade: 3, ER/PR: Negative, HER2: Negative, Ki67: 25%","Adjuvant Chemotherapy, Targeted Therapy, Radiotherapy",,1,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
425,63,Female,Breast Cancer,newly diagnosed,"Size: 5cm, Grade: 3, ER/PR: Negative, HER2: Negative, Ki67: 65%","Neoadjuvant Chemotherapy, Endocrine Therapy, ","BRCA2, ",2,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
426,36,Female,Breast Cancer,newly diagnosed,"Size: 5cm, Grade: 3, ER/PR: Negative, HER2: Negative, Ki67: 29%","Neoadjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, Radiotherapy","BRCA1, ",2,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
427,33,Female,Breast Cancer,newly diagnosed,"Size: 6cm, Grade: 4, ER/PR: Negative, HER2: Negative, Ki67: 95%","Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, ",,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
428,38,Female,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 73%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Endocrine Therapy, ",,2,Impaired,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
429,28,Female,Breast Cancer,newly diagnosed,"Size: 5cm, Grade: 2, ER/PR: Negative, HER2: Positive, Ki67: 11%","Neoadjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, ",,2,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
430,69,Male,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 2, ER/PR: Negative, HER2: Positive, Ki67: 86%","Endocrine Therapy, ",,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
431,42,Female,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 3, ER/PR: Positive, HER2: Positive, Ki67: 48%","Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, ",,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,f
432,51,Female,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 1, ER/PR: Negative, HER2: Negative, Ki67: 13%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Endocrine Therapy, ",,0,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
433,19,Female,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 3, ER/PR: Negative, HER2: Positive, Ki67: 77%","Adjuvant Chemotherapy, Targeted Therapy, Radiotherapy",TP53,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
434,46,Female,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 3, ER/PR: Positive, HER2: Negative, Ki67: 97%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, ","BRCA1, ",2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,f
435,47,Female,Breast Cancer,newly diagnosed,"Size: 6cm, Grade: 3, ER/PR: Negative, HER2: Negative, Ki67: 63%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, ",,2,Impaired,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
436,44,Female,Breast Cancer,relapsed,"Size: 2cm, Grade: 1, ER/PR: Negative, HER2: Negative, Ki67: 90%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, ",,1,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
437,76,Male,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 2, ER/PR: Positive, HER2: Positive, Ki67: 30%","Adjuvant Chemotherapy, Endocrine Therapy, ",,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
438,31,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 3, ER/PR: Positive, HER2: Positive, Ki67: 44%",,,2,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
439,26,Female,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 1, ER/PR: Positive, HER2: Positive, Ki67: 18%","Targeted Therapy, Radiotherapy",,0,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
440,19,Female,Breast Cancer,newly diagnosed,"Size: 6cm, Grade: 2, ER/PR: Positive, HER2: Positive, Ki67: 19%","Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, ",,3,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
441,38,Female,Breast Cancer,relapsed,"Size: 4cm, Grade: 1, ER/PR: Positive, HER2: Negative, Ki67: 14%","Adjuvant Chemotherapy, Radiotherapy","BRCA1, BRCA2, ",1,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
442,68,Female,Breast Cancer,relapsed,"Size: 2cm, Grade: 1, ER/PR: Negative, HER2: Positive, Ki67: 59%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Radiotherapy",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
443,75,Female,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 3, ER/PR: Positive, HER2: Negative, Ki67: 16%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Endocrine Therapy, Radiotherapy","PIK3CA, BRCA2, ",2,Impaired,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
444,46,Female,Breast Cancer,relapsed,"Size: 2cm, Grade: 3, ER/PR: Positive, HER2: Negative, Ki67: 75%","Neoadjuvant Chemotherapy, ",TP53,2,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
445,75,Female,Breast Cancer,newly diagnosed,"Size: 5cm, Grade: 3, ER/PR: Negative, HER2: Negative, Ki67: 38%","Adjuvant Chemotherapy, Targeted Therapy, Radiotherapy","BRCA2, ",2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
446,63,Female,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 3, ER/PR: Negative, HER2: Negative, Ki67: 49%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, ",,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
447,53,Female,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 3, ER/PR: Negative, HER2: Negative, Ki67: 46%","Targeted Therapy, Endocrine Therapy, Radiotherapy","PIK3CA, TP53",2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
448,67,Female,Breast Cancer,relapsed,"Size: 2cm, Grade: 1, ER/PR: Positive, HER2: Positive, Ki67: 92%","Neoadjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, Radiotherapy","PIK3CA, BRCA1, ",1,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
449,54,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 77%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, Radiotherapy",TP53,3,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
450,61,Female,Breast Cancer,relapsed,"Size: 5cm, Grade: 4, ER/PR: Positive, HER2: Negative, Ki67: 84%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Endocrine Therapy, Radiotherapy",,3,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
451,78,Female,Breast Cancer,relapsed,"Size: 2cm, Grade: 1, ER/PR: Negative, HER2: Negative, Ki67: 1%","Targeted Therapy, Endocrine Therapy, Radiotherapy",,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Pregnant/Breastfeeding,t
452,77,Female,Breast Cancer,newly diagnosed,"Size: 5cm, Grade: 3, ER/PR: Positive, HER2: Negative, Ki67: 37%","Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, Radiotherapy",,0,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
453,67,Male,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 3, ER/PR: Positive, HER2: Negative, Ki67: 57%","Adjuvant Chemotherapy, Endocrine Therapy, ","PIK3CA, ",2,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
454,43,Female,Breast Cancer,newly diagnosed,"Size: 1cm, Grade: 2, ER/PR: Positive, HER2: Positive, Ki67: 48%","Adjuvant Chemotherapy, Endocrine Therapy, ",,0,Impaired,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,f
455,54,Female,Breast Cancer,relapsed,"Size: 2cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 7%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Radiotherapy","PIK3CA, BRCA1, ",3,Normal,t,Risk features,Comorbidities,Previous cancer history,Pregnant/Breastfeeding,t
456,41,Female,Breast Cancer,newly diagnosed,"Size: 5cm, Grade: 3, ER/PR: Positive, HER2: Negative, Ki67: 88%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, ",,3,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
457,70,Female,Breast Cancer,relapsed,"Size: 4cm, Grade: 2, ER/PR: Positive, HER2: Positive, Ki67: 82%",Radiotherapy,,0,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
458,54,Female,Breast Cancer,relapsed,"Size: 2cm, Grade: 4, ER/PR: Negative, HER2: Negative, Ki67: 89%","Targeted Therapy, Radiotherapy",,2,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
459,32,Female,Breast Cancer,newly diagnosed,"Size: 6cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 43%","Neoadjuvant Chemotherapy, Endocrine Therapy, Radiotherapy","BRCA2, ",1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
460,71,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 1, ER/PR: Positive, HER2: Negative, Ki67: 22%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, Radiotherapy","BRCA1, ",0,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
461,40,Female,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 4, ER/PR: Negative, HER2: Positive, Ki67: 66%","Neoadjuvant Chemotherapy, Endocrine Therapy, Radiotherapy",,2,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
462,33,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 71%","Targeted Therapy, Endocrine Therapy, Radiotherapy",,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
463,21,Female,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 3, ER/PR: Negative, HER2: Negative, Ki67: 9%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Endocrine Therapy, Radiotherapy",,1,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
464,72,Female,Breast Cancer,relapsed,"Size: 5cm, Grade: 3, ER/PR: Positive, HER2: Negative, Ki67: 84%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Endocrine Therapy, Radiotherapy",,0,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,f
465,50,Female,Breast Cancer,newly diagnosed,"Size: 1cm, Grade: 4, ER/PR: Negative, HER2: Positive, Ki67: 27%","Neoadjuvant Chemotherapy, Endocrine Therapy, Radiotherapy",,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
466,73,Female,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 2, ER/PR: Positive, HER2: Positive, Ki67: 94%","Adjuvant Chemotherapy, Radiotherapy","BRCA2, ",1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
467,54,Female,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 2, ER/PR: Negative, HER2: Negative, Ki67: 23%","Endocrine Therapy, Radiotherapy",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
468,79,Female,Breast Cancer,newly diagnosed,"Size: 5cm, Grade: 2, ER/PR: Positive, HER2: Negative, Ki67: 2%",Radiotherapy,"BRCA2, ",3,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
469,42,Female,Breast Cancer,relapsed,"Size: 2cm, Grade: 4, ER/PR: Negative, HER2: Negative, Ki67: 33%","Neoadjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, ",,2,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
470,66,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 3, ER/PR: Positive, HER2: Negative, Ki67: 99%","Targeted Therapy, Endocrine Therapy, ",,0,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
471,71,Female,Breast Cancer,newly diagnosed,"Size: 1cm, Grade: 2, ER/PR: Positive, HER2: Negative, Ki67: 32%","Neoadjuvant Chemotherapy, Endocrine Therapy, Radiotherapy","BRCA2, ",2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
472,19,Female,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 2, ER/PR: Positive, HER2: Positive, Ki67: 43%","Endocrine Therapy, ",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
473,71,Female,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 3, ER/PR: Positive, HER2: Positive, Ki67: 33%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Endocrine Therapy, ",,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
474,68,Female,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 3, ER/PR: Negative, HER2: Negative, Ki67: 64%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, ",,0,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
475,56,Female,Breast Cancer,newly diagnosed,"Size: 6cm, Grade: 2, ER/PR: Positive, HER2: Negative, Ki67: 49%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Radiotherapy",,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
476,77,Female,Breast Cancer,relapsed,"Size: 4cm, Grade: 3, ER/PR: Negative, HER2: Negative, Ki67: 61%","Neoadjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, Radiotherapy",,0,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
477,64,Female,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 1, ER/PR: Negative, HER2: Negative, Ki67: 19%",,,0,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,f
478,29,Female,Breast Cancer,newly diagnosed,"Size: 5cm, Grade: 2, ER/PR: Positive, HER2: Positive, Ki67: 7%",Radiotherapy,,3,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
479,58,Female,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 4, ER/PR: Negative, HER2: Positive, Ki67: 11%","Neoadjuvant Chemotherapy, Targeted Therapy, Radiotherapy","BRCA1, TP53",3,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
480,29,Female,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 1, ER/PR: Positive, HER2: Positive, Ki67: 25%","Adjuvant Chemotherapy, Targeted Therapy, ",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
481,52,Female,Breast Cancer,newly diagnosed,"Size: 1cm, Grade: 4, ER/PR: Negative, HER2: Negative, Ki67: 19%","Neoadjuvant Chemotherapy, Targeted Therapy, Radiotherapy",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
482,34,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 4, ER/PR: Negative, HER2: Positive, Ki67: 72%","Targeted Therapy, Endocrine Therapy, Radiotherapy",,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
483,56,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 3, ER/PR: Negative, HER2: Positive, Ki67: 25%","Neoadjuvant Chemotherapy, Radiotherapy",,2,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
484,73,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 1, ER/PR: Negative, HER2: Negative, Ki67: 41%","Neoadjuvant Chemotherapy, Endocrine Therapy, ",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
485,70,Female,Breast Cancer,newly diagnosed,"Size: 1cm, Grade: 3, ER/PR: Positive, HER2: Negative, Ki67: 11%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, Radiotherapy",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
486,48,Female,Breast Cancer,newly diagnosed,"Size: 6cm, Grade: 1, ER/PR: Positive, HER2: Positive, Ki67: 1%","Targeted Therapy, Endocrine Therapy, ",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
487,41,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 1, ER/PR: Negative, HER2: Positive, Ki67: 92%","Targeted Therapy, ",,1,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
488,71,Female,Breast Cancer,newly diagnosed,"Size: 6cm, Grade: 1, ER/PR: Negative, HER2: Negative, Ki67: 12%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Radiotherapy",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
489,33,Female,Breast Cancer,newly diagnosed,"Size: 3cm, Grade: 4, ER/PR: Negative, HER2: Negative, Ki67: 49%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, ",,3,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
490,70,Female,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 3, ER/PR: Negative, HER2: Positive, Ki67: 93%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, ",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
491,43,Female,Breast Cancer,newly diagnosed,"Size: 5cm, Grade: 3, ER/PR: Negative, HER2: Positive, Ki67: 84%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, Endocrine Therapy, ","PIK3CA, ",1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
492,72,Female,Breast Cancer,newly diagnosed,"Size: 5cm, Grade: 1, ER/PR: Positive, HER2: Positive, Ki67: 92%","Adjuvant Chemotherapy, Endocrine Therapy, Radiotherapy","BRCA2, ",1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
493,65,Female,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 3, ER/PR: Negative, HER2: Positive, Ki67: 13%","Targeted Therapy, Radiotherapy",,3,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
494,34,Female,Breast Cancer,relapsed,"Size: 2cm, Grade: 2, ER/PR: Negative, HER2: Positive, Ki67: 17%","Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, Radiotherapy",,3,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
495,65,Female,Breast Cancer,relapsed,"Size: 3cm, Grade: 4, ER/PR: Negative, HER2: Positive, Ki67: 96%","Neoadjuvant Chemotherapy, Adjuvant Chemotherapy, ",,2,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
496,59,Female,Breast Cancer,newly diagnosed,"Size: 4cm, Grade: 2, ER/PR: Positive, HER2: Negative, Ki67: 29%",,,1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
497,78,Female,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 3, ER/PR: Positive, HER2: Negative, Ki67: 55%","Neoadjuvant Chemotherapy, Endocrine Therapy, ",,2,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
498,45,Female,Breast Cancer,relapsed,"Size: 6cm, Grade: 2, ER/PR: Positive, HER2: Positive, Ki67: 51%","Endocrine Therapy, ",,2,Normal,t,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
499,20,Female,Breast Cancer,newly diagnosed,"Size: 2cm, Grade: 3, ER/PR: Negative, HER2: Negative, Ki67: 14%","Adjuvant Chemotherapy, Endocrine Therapy, ","PIK3CA, ",1,Normal,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
500,20,Female,Breast Cancer,relapsed,"Size: 4cm, Grade: 3, ER/PR: Negative, HER2: Negative, Ki67: 80%","Adjuvant Chemotherapy, Targeted Therapy, Endocrine Therapy, Radiotherapy",,0,Impaired,f,Risk features,Comorbidities,Previous cancer history,Not Applicable,t
